The forecast indicates that hospital discharges for dermatitis, eczema, and papulosquamous disorders in Germany grow steadily from 2024 to 2028. In 2023, actual discharges stood at 81.2 thousand. The annual growth rates are approximately 1.66% between 2024 and 2025, 1.59% from 2025 to 2026, 1.57% between 2026 and 2027, and 1.52% from 2027 to 2028. The compound annual growth rate (CAGR) for these years averages around 1.6%, demonstrating a consistent upward trend over the period.

Future trends to watch for:

Potential breakthroughs in dermatological treatments reducing the need for hospital stays.
Impact of demographic changes on the prevalence of these conditions.
Innovation in telemedicine and outpatient care shifting discharges away from hospitals.